European Archives - Page 125 of 1369 - European Medical Journal

ESC 2025 Interview: Florian A. Wenzl

ESC 2025 Interview: Florian A. Wenzl: Center for Molecular Cardiology, University of Zurich, Switzerland; NHS England, London, UK…

ERS 2025: Father’s Smoking in Puberty Accelerates Ageing in Offspring

New ERS 2025 research links paternal smoking in puberty with accelerated biological ageing in offspring, reinforcing evidence of intergenerational tobacco harms.

Bladder

Bladder Cancer Organoids and Personalised Therapies

Recent advances in three-dimensional (3D) culture technology have transformed the way researchers study bladder cancer.

remote monitoring

ERS 2025: Remote Monitoring Improves Asthma Outcomes for Children

A multicentre study presented at ERS Congress 2025 found that remote monitoring reduced hospital visits and improved asthma control in children, strengthening the case for digital health in routine asthma care.

Adult smoking in front of child

Paternal Smoke Exposure Linked to Lifelong Lung Damage in Children

New research shows that paternal smoke exposure before puberty is associated with reduced lung function trajectories in offspring, increasing long-term respiratory risk.

blood cells

Medical Imaging Linked to Increased Childhood Cancer Risk

Discover how a recent cohort study links medical imaging radiation to increased childhood haematologic cancer risk.

Human brain in a glass of beer

Alcohol and Dementia Risk Linked Across Large Cohorts

Large-scale observational and genetic analyses reveal that alcohol consumption is associated with higher dementia risk. Genetic evidence contradicts protective effects of light drinking.

Inside Healthcare Communications

In this series, host Jonathan Sackier speaks with Jed Beitler about the evolution of healthcare communications and its impact on global health.

fatigue

Multidimensional Fatigue During Cervical Cancer Brachytherapy

A longitudinal study of 188 cervical cancer patients undergoing brachytherapy revealed that multidimensional fatigue slightly increased during treatment, peaking after five sessions, then significantly decreased one month post-treatment.

Young girl administering shot

Low-dose ATG Shows Promise for Type 1 Diabetes Treatment

Learn how low-dose ATG may preserve β-cell function in young people with recent-onset Type 1 diabetes.